| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | importin-alpha family protein binding | 7.61e-06 | 21 | 37 | 3 | GO:0061676 | |
| GeneOntologyMolecularFunction | kinase binding | 3.28e-04 | 969 | 37 | 8 | GO:0019900 | |
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 5.02e-04 | 18 | 37 | 2 | GO:0008569 | |
| GeneOntologyMolecularFunction | syntaxin binding | 5.58e-04 | 87 | 37 | 3 | GO:0019905 | |
| GeneOntologyMolecularFunction | protein kinase binding | 9.72e-04 | 873 | 37 | 7 | GO:0019901 | |
| GeneOntologyMolecularFunction | dynein light intermediate chain binding | 1.23e-03 | 28 | 37 | 2 | GO:0051959 | |
| GeneOntologyMolecularFunction | SNARE binding | 2.03e-03 | 136 | 37 | 3 | GO:0000149 | |
| GeneOntologyMolecularFunction | dynein intermediate chain binding | 2.14e-03 | 37 | 37 | 2 | GO:0045505 | |
| GeneOntologyMolecularFunction | microtubule binding | 2.46e-03 | 308 | 37 | 4 | GO:0008017 | |
| GeneOntologyBiologicalProcess | Golgi organization | 3.12e-08 | 168 | 40 | 7 | GO:0007030 | |
| GeneOntologyBiologicalProcess | Golgi disassembly | 5.40e-06 | 18 | 40 | 3 | GO:0090166 | |
| GeneOntologyBiologicalProcess | positive regulation of protein glycosylation | 6.41e-06 | 19 | 40 | 3 | GO:0060050 | |
| GeneOntologyBiologicalProcess | Golgi ribbon formation | 1.16e-05 | 23 | 40 | 3 | GO:0090161 | |
| GeneOntologyBiologicalProcess | regulation of protein glycosylation | 1.33e-05 | 24 | 40 | 3 | GO:0060049 | |
| GeneOntologyBiologicalProcess | Golgi localization | 1.91e-05 | 27 | 40 | 3 | GO:0051645 | |
| GeneOntologyBiologicalProcess | meiotic spindle assembly | 2.14e-05 | 28 | 40 | 3 | GO:0090306 | |
| GeneOntologyBiologicalProcess | organelle inheritance | 2.14e-05 | 28 | 40 | 3 | GO:0048308 | |
| GeneOntologyBiologicalProcess | Golgi inheritance | 2.14e-05 | 28 | 40 | 3 | GO:0048313 | |
| GeneOntologyBiologicalProcess | regulation of axonogenesis | 3.35e-05 | 192 | 40 | 5 | GO:0050770 | |
| GeneOntologyBiologicalProcess | endomembrane system organization | 3.72e-05 | 672 | 40 | 8 | GO:0010256 | |
| GeneOntologyBiologicalProcess | asymmetric cell division | 3.88e-05 | 34 | 40 | 3 | GO:0008356 | |
| GeneOntologyBiologicalProcess | positive regulation of glycoprotein biosynthetic process | 4.61e-05 | 36 | 40 | 3 | GO:0010560 | |
| GeneOntologyBiologicalProcess | organelle assembly | RNF213 GOLGA8M LRBA SPAG17 GOLGA8O SYNE1 WNT5A DNAH17 GOLGA8N DNAH1 | 4.66e-05 | 1138 | 40 | 10 | GO:0070925 |
| GeneOntologyBiologicalProcess | meiotic spindle organization | 5.02e-05 | 37 | 40 | 3 | GO:0000212 | |
| GeneOntologyBiologicalProcess | positive regulation of glycoprotein metabolic process | 6.35e-05 | 40 | 40 | 3 | GO:1903020 | |
| GeneOntologyBiologicalProcess | regulation of protein binding | 7.58e-05 | 228 | 40 | 5 | GO:0043393 | |
| GeneOntologyBiologicalProcess | positive regulation of neuron maturation | 7.65e-05 | 7 | 40 | 2 | GO:0014042 | |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | 7.91e-05 | 748 | 40 | 8 | GO:0048667 | |
| GeneOntologyBiologicalProcess | neuron projection morphogenesis | 1.28e-04 | 802 | 40 | 8 | GO:0048812 | |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | 1.48e-04 | 819 | 40 | 8 | GO:0120039 | |
| GeneOntologyBiologicalProcess | regulation of neuron projection development | 1.56e-04 | 612 | 40 | 7 | GO:0010975 | |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | 1.57e-04 | 826 | 40 | 8 | GO:0048858 | |
| GeneOntologyBiologicalProcess | microtubule nucleation | 1.84e-04 | 57 | 40 | 3 | GO:0007020 | |
| GeneOntologyBiologicalProcess | regulation of anatomical structure morphogenesis | 1.93e-04 | 1090 | 40 | 9 | GO:0022603 | |
| GeneOntologyBiologicalProcess | midgut development | 2.39e-04 | 12 | 40 | 2 | GO:0007494 | |
| GeneOntologyBiologicalProcess | regulation of glycoprotein biosynthetic process | 3.24e-04 | 69 | 40 | 3 | GO:0010559 | |
| GeneOntologyBiologicalProcess | positive regulation of cell maturation | 3.29e-04 | 14 | 40 | 2 | GO:1903431 | |
| GeneOntologyBiologicalProcess | positive regulation of cell projection organization | 3.52e-04 | 494 | 40 | 6 | GO:0031346 | |
| GeneOntologyBiologicalProcess | positive regulation of protein modification process | 3.70e-04 | 937 | 40 | 8 | GO:0031401 | |
| GeneOntologyBiologicalProcess | cell morphogenesis | 3.79e-04 | 1194 | 40 | 9 | GO:0000902 | |
| GeneOntologyBiologicalProcess | response to stimulus involved in regulation of muscle adaptation | 4.33e-04 | 16 | 40 | 2 | GO:0014874 | |
| GeneOntologyBiologicalProcess | protein homotetramerization | 4.47e-04 | 77 | 40 | 3 | GO:0051289 | |
| GeneOntologyBiologicalProcess | regulation of glycoprotein metabolic process | 5.01e-04 | 80 | 40 | 3 | GO:1903018 | |
| GeneOntologyBiologicalProcess | regulation of neuron maturation | 5.50e-04 | 18 | 40 | 2 | GO:0014041 | |
| GeneOntologyBiologicalProcess | positive regulation of neurogenesis | 5.82e-04 | 354 | 40 | 5 | GO:0050769 | |
| GeneOntologyBiologicalProcess | organelle disassembly | 6.43e-04 | 204 | 40 | 4 | GO:1903008 | |
| GeneOntologyBiologicalProcess | axonogenesis | 7.22e-04 | 566 | 40 | 6 | GO:0007409 | |
| GeneOntologyBiologicalProcess | mitotic spindle assembly | 7.53e-04 | 92 | 40 | 3 | GO:0090307 | |
| GeneOntologyBiologicalProcess | regulation of binding | 9.63e-04 | 396 | 40 | 5 | GO:0051098 | |
| GeneOntologyBiologicalProcess | positive regulation of peptidyl-serine phosphorylation | 9.87e-04 | 101 | 40 | 3 | GO:0033138 | |
| GeneOntologyBiologicalProcess | regulation of dendrite morphogenesis | 1.04e-03 | 103 | 40 | 3 | GO:0048814 | |
| GeneOntologyBiologicalProcess | activation of protein kinase B activity | 1.07e-03 | 25 | 40 | 2 | GO:0032148 | |
| GeneOntologyBiologicalProcess | regulation of plasma membrane bounded cell projection organization | 1.09e-03 | 846 | 40 | 7 | GO:0120035 | |
| GeneOntologyBiologicalProcess | positive regulation of cell development | 1.10e-03 | 614 | 40 | 6 | GO:0010720 | |
| GeneOntologyBiologicalProcess | cellular component disassembly | 1.13e-03 | 617 | 40 | 6 | GO:0022411 | |
| GeneOntologyBiologicalProcess | negative regulation of protein binding | 1.14e-03 | 106 | 40 | 3 | GO:0032091 | |
| GeneOntologyBiologicalProcess | meiotic nuclear division | 1.18e-03 | 240 | 40 | 4 | GO:0140013 | |
| GeneOntologyBiologicalProcess | regulation of cell projection organization | 1.22e-03 | 863 | 40 | 7 | GO:0031344 | |
| GeneOntologyBiologicalProcess | positive regulation of nervous system development | 1.22e-03 | 418 | 40 | 5 | GO:0051962 | |
| GeneOntologyBiologicalProcess | axoneme assembly | 1.23e-03 | 109 | 40 | 3 | GO:0035082 | |
| GeneOntologyBiologicalProcess | negative regulation of autophagy | 1.33e-03 | 112 | 40 | 3 | GO:0010507 | |
| GeneOntologyBiologicalProcess | protein tetramerization | 1.36e-03 | 113 | 40 | 3 | GO:0051262 | |
| GeneOntologyBiologicalProcess | axon development | 1.38e-03 | 642 | 40 | 6 | GO:0061564 | |
| GeneOntologyBiologicalProcess | positive regulation of axonogenesis | 1.40e-03 | 114 | 40 | 3 | GO:0050772 | |
| GeneOntologyBiologicalProcess | type B pancreatic cell development | 1.44e-03 | 29 | 40 | 2 | GO:0003323 | |
| GeneOntologyBiologicalProcess | process utilizing autophagic mechanism | 1.47e-03 | 650 | 40 | 6 | GO:0061919 | |
| GeneOntologyBiologicalProcess | autophagy | 1.47e-03 | 650 | 40 | 6 | GO:0006914 | |
| GeneOntologyBiologicalProcess | microtubule polymerization | 1.51e-03 | 117 | 40 | 3 | GO:0046785 | |
| GeneOntologyBiologicalProcess | meiotic chromosome segregation | 1.70e-03 | 122 | 40 | 3 | GO:0045132 | |
| GeneOntologyBiologicalProcess | regulation of non-canonical Wnt signaling pathway | 1.75e-03 | 32 | 40 | 2 | GO:2000050 | |
| GeneOntologyBiologicalProcess | meiotic cell cycle process | 1.76e-03 | 268 | 40 | 4 | GO:1903046 | |
| GeneOntologyCellularComponent | Golgi cis cisterna | 3.54e-11 | 33 | 40 | 6 | GO:0000137 | |
| GeneOntologyCellularComponent | cis-Golgi network | 1.30e-08 | 85 | 40 | 6 | GO:0005801 | |
| GeneOntologyCellularComponent | Golgi cisterna membrane | 2.39e-08 | 94 | 40 | 6 | GO:0032580 | |
| GeneOntologyCellularComponent | Golgi apparatus subcompartment | GOLGA8R GOLGA8S GOLGA8M CLTCL1 LRBA GOLGA8O VAMP5 GOLGA8Q GOLGA8N | 1.21e-07 | 443 | 40 | 9 | GO:0098791 |
| GeneOntologyCellularComponent | Golgi cisterna | 2.08e-07 | 135 | 40 | 6 | GO:0031985 | |
| GeneOntologyCellularComponent | Golgi stack | 8.36e-07 | 171 | 40 | 6 | GO:0005795 | |
| GeneOntologyCellularComponent | supramolecular fiber | GOLGA8M FBXO32 SPAG17 ARHGEF25 GOLGA8O OPA1 SYNE1 DNAH17 GOLGA8N DNAH1 | 5.62e-05 | 1179 | 40 | 10 | GO:0099512 |
| GeneOntologyCellularComponent | supramolecular polymer | GOLGA8M FBXO32 SPAG17 ARHGEF25 GOLGA8O OPA1 SYNE1 DNAH17 GOLGA8N DNAH1 | 5.95e-05 | 1187 | 40 | 10 | GO:0099081 |
| GeneOntologyCellularComponent | microtubule | 6.05e-05 | 533 | 40 | 7 | GO:0005874 | |
| GeneOntologyCellularComponent | coated vesicle | 5.91e-04 | 360 | 40 | 5 | GO:0030135 | |
| GeneOntologyCellularComponent | axonemal dynein complex | 1.04e-03 | 25 | 40 | 2 | GO:0005858 | |
| GeneOntologyCellularComponent | COPII-coated ER to Golgi transport vesicle | 1.22e-03 | 110 | 40 | 3 | GO:0030134 | |
| GeneOntologyCellularComponent | polymeric cytoskeletal fiber | 1.43e-03 | 899 | 40 | 7 | GO:0099513 | |
| GeneOntologyCellularComponent | somatodendritic compartment | 1.98e-03 | 1228 | 40 | 8 | GO:0036477 | |
| GeneOntologyCellularComponent | plasma membrane bounded cell projection cytoplasm | 3.08e-03 | 317 | 40 | 4 | GO:0032838 | |
| MousePheno | abnormal pulmonary alveolus morphology | 1.12e-06 | 255 | 31 | 7 | MP:0002270 | |
| MousePheno | abnormal pulmonary acinus morphology | 2.30e-06 | 284 | 31 | 7 | MP:0010911 | |
| MousePheno | abnormal pulmonary alveolar system morphology | 3.02e-06 | 296 | 31 | 7 | MP:0010899 | |
| MousePheno | increased alveolar macrophage number | 3.54e-06 | 14 | 31 | 3 | MP:0014228 | |
| MousePheno | abnormal lung morphology | GPI GOLGA8M RET SPAG17 GOLGA8O VAMP5 SYNE1 WNT5A SPTA1 GOLGA8N | 3.61e-06 | 767 | 31 | 10 | MP:0001175 |
| MousePheno | abnormal alveolar macrophage number | 4.41e-06 | 15 | 31 | 3 | MP:0014227 | |
| MousePheno | pulmonary fibrosis | 4.60e-06 | 51 | 31 | 4 | MP:0006050 | |
| MousePheno | immotile sperm | 8.27e-06 | 59 | 31 | 4 | MP:0020869 | |
| MousePheno | abnormal Golgi vesicle transport | 1.48e-05 | 22 | 31 | 3 | MP:0030949 | |
| MousePheno | abnormal proacrosomal vesicle fusion | 1.94e-05 | 24 | 31 | 3 | MP:0031355 | |
| MousePheno | abnormal sperm nucleus morphology | 2.04e-05 | 74 | 31 | 4 | MP:0009232 | |
| MousePheno | globozoospermia | 2.04e-05 | 74 | 31 | 4 | MP:0002686 | |
| MousePheno | abnormal acrosome morphology | 2.39e-05 | 159 | 31 | 5 | MP:0008898 | |
| MousePheno | abnormal pulmonary alveolus epithelium morphology | 2.78e-05 | 80 | 31 | 4 | MP:0010898 | |
| MousePheno | abnormal alveolar macrophage morphology | 2.79e-05 | 27 | 31 | 3 | MP:0008245 | |
| MousePheno | absent sperm mitochondrial sheath | 3.12e-05 | 28 | 31 | 3 | MP:0009833 | |
| MousePheno | abnormal respiratory system morphology | GPI GOLGA8M RET SPAG17 GOLGA8O VAMP5 SYNE1 WNT5A SPTA1 GOLGA8N | 4.67e-05 | 1027 | 31 | 10 | MP:0002132 |
| MousePheno | absent acrosome | 4.69e-05 | 32 | 31 | 3 | MP:0008839 | |
| MousePheno | abnormal acrosome assembly | 4.82e-05 | 92 | 31 | 4 | MP:0031354 | |
| MousePheno | abnormal Golgi apparatus morphology | 5.15e-05 | 33 | 31 | 3 | MP:0011743 | |
| MousePheno | abnormal actin cytoskeleton morphology | 5.64e-05 | 34 | 31 | 3 | MP:0020849 | |
| MousePheno | decreased sperm progressive motility | 6.69e-05 | 100 | 31 | 4 | MP:0020451 | |
| MousePheno | abnormal sperm progressive motility | 6.95e-05 | 101 | 31 | 4 | MP:0020450 | |
| MousePheno | abnormal presomitic mesoderm morphology | 7.10e-05 | 6 | 31 | 2 | MP:0012182 | |
| MousePheno | abnormal cell motility | GOLGA8M RET SPAG17 GOLGA8O WNT5A DNAH17 GOLGA8N SH2D3C DNAH1 | 8.90e-05 | 885 | 31 | 9 | MP:0020846 |
| MousePheno | asthenozoospermia | 1.23e-04 | 362 | 31 | 6 | MP:0002675 | |
| MousePheno | abnormal lung epithelium morphology | 1.27e-04 | 118 | 31 | 4 | MP:0006382 | |
| MousePheno | abnormal liver lobule morphology | 1.36e-04 | 229 | 31 | 5 | MP:0008987 | |
| MousePheno | abnormal microtubule cytoskeleton morphology | 1.41e-04 | 46 | 31 | 3 | MP:0020850 | |
| MousePheno | abnormal spermiogenesis | 1.59e-04 | 237 | 31 | 5 | MP:0001932 | |
| MousePheno | abnormal liver parenchyma morphology | 1.79e-04 | 243 | 31 | 5 | MP:0008986 | |
| MousePheno | abnormal sperm motility | 2.15e-04 | 401 | 31 | 6 | MP:0002674 | |
| MousePheno | abnormal sperm head morphology | 2.49e-04 | 261 | 31 | 5 | MP:0009230 | |
| MousePheno | abnormal surfactant physiology | 2.81e-04 | 58 | 31 | 3 | MP:0004782 | |
| MousePheno | abnormal sperm physiology | 3.86e-04 | 447 | 31 | 6 | MP:0004543 | |
| MousePheno | abnormal type II pneumocyte morphology | 4.30e-04 | 67 | 31 | 3 | MP:0002275 | |
| MousePheno | decreased Purkinje cell number | 4.30e-04 | 67 | 31 | 3 | MP:0000880 | |
| MousePheno | abnormal sperm flagellum morphology | 4.38e-04 | 295 | 31 | 5 | MP:0008892 | |
| MousePheno | abnormal Purkinje cell number | 4.69e-04 | 69 | 31 | 3 | MP:0000878 | |
| MousePheno | abnormal hepatocyte morphology | 4.70e-04 | 166 | 31 | 4 | MP:0000607 | |
| MousePheno | dilated ureter | 5.60e-04 | 16 | 31 | 2 | MP:0003586 | |
| MousePheno | abnormal respiratory system physiology | 5.84e-04 | 897 | 31 | 8 | MP:0002133 | |
| MousePheno | abnormal cell cytoskeleton morphology | 5.99e-04 | 75 | 31 | 3 | MP:0020378 | |
| MousePheno | abnormal pulmonary alveolus epithelial cell morphology | 6.46e-04 | 77 | 31 | 3 | MP:0002273 | |
| MousePheno | liver fibrosis | 6.46e-04 | 77 | 31 | 3 | MP:0003333 | |
| MousePheno | abnormal male genitalia morphology | GOLGA8M RET MANBA SPAG17 GOLGA8O KLRB1 WNT5A PDPK1 GOLGA8N SH2D3C | 6.62e-04 | 1415 | 31 | 10 | MP:0009198 |
| MousePheno | abnormal male reproductive system morphology | GOLGA8M RET MANBA SPAG17 GOLGA8O KLRB1 WNT5A PDPK1 GOLGA8N SH2D3C | 6.62e-04 | 1415 | 31 | 10 | MP:0001145 |
| MousePheno | infertility | GOLGA8M RET SPAG17 GOLGA8O CCDC191 SPTA1 DNAH17 GOLGA8N DNAH1 | 8.10e-04 | 1188 | 31 | 9 | MP:0001924 |
| MousePheno | male infertility | 8.19e-04 | 944 | 31 | 8 | MP:0001925 | |
| MousePheno | abnormal professional antigen presenting cell morphology | 8.71e-04 | 726 | 31 | 7 | MP:0008195 | |
| MousePheno | abnormal pulmonary alveolar parenchyma morphology | 1.02e-03 | 90 | 31 | 3 | MP:0010901 | |
| MousePheno | abnormal sperm mitochondrial sheath morphology | 1.19e-03 | 95 | 31 | 3 | MP:0009832 | |
| MousePheno | abnormal motile cilium morphology | 1.22e-03 | 370 | 31 | 5 | MP:0013206 | |
| MousePheno | abnormal spermatid morphology | 1.28e-03 | 217 | 31 | 4 | MP:0006380 | |
| MousePheno | decreased neuron number | 1.31e-03 | 376 | 31 | 5 | MP:0008948 | |
| MousePheno | oligozoospermia | 1.44e-03 | 384 | 31 | 5 | MP:0002687 | |
| MousePheno | absent gastric milk in neonates | 1.46e-03 | 102 | 31 | 3 | MP:0009546 | |
| MousePheno | abnormal cerebellum morphology | 1.52e-03 | 389 | 31 | 5 | MP:0000849 | |
| MousePheno | abnormal respiratory epithelium morphology | 1.71e-03 | 235 | 31 | 4 | MP:0010942 | |
| MousePheno | atelectasis | 1.72e-03 | 108 | 31 | 3 | MP:0001177 | |
| MousePheno | decreased somite size | 1.74e-03 | 28 | 31 | 2 | MP:0011732 | |
| MousePheno | abnormal male reproductive system physiology | GOLGA8M RET SPAG17 GOLGA8O POU5F2 CCDC191 DNAH17 GOLGA8N DNAH1 | 1.80e-03 | 1329 | 31 | 9 | MP:0003698 |
| MousePheno | teratozoospermia | 1.88e-03 | 408 | 31 | 5 | MP:0005578 | |
| MousePheno | abnormal erythrocyte osmotic lysis | 1.99e-03 | 30 | 31 | 2 | MP:0003657 | |
| MousePheno | abnormal metencephalon morphology | 2.13e-03 | 420 | 31 | 5 | MP:0000847 | |
| MousePheno | abnormal cilium morphology | 2.43e-03 | 433 | 31 | 5 | MP:0013202 | |
| MousePheno | abnormal internal male genitalia morphology | 2.49e-03 | 1392 | 31 | 9 | MP:0009205 | |
| MousePheno | hemolysis | 2.55e-03 | 34 | 31 | 2 | MP:0010163 | |
| MousePheno | perinatal lethality | 2.61e-03 | 1130 | 31 | 8 | MP:0002081 | |
| MousePheno | ataxia | 2.69e-03 | 266 | 31 | 4 | MP:0001393 | |
| MousePheno | aphagia | 2.86e-03 | 129 | 31 | 3 | MP:0001438 | |
| MousePheno | abnormal somite size | 2.86e-03 | 36 | 31 | 2 | MP:0005222 | |
| MousePheno | hindlimb paresis | 3.02e-03 | 37 | 31 | 2 | MP:0031204 | |
| MousePheno | abnormal liver morphology | 3.04e-03 | 1433 | 31 | 9 | MP:0000598 | |
| MousePheno | abnormal neuron number | 3.04e-03 | 456 | 31 | 5 | MP:0008946 | |
| MousePheno | abnormal macrophage cell number | 3.16e-03 | 278 | 31 | 4 | MP:0020202 | |
| MousePheno | abnormal macrophage morphology | 3.25e-03 | 463 | 31 | 5 | MP:0002446 | |
| Domain | GOLGA2L5 | 3.91e-08 | 18 | 37 | 4 | PF15070 | |
| Domain | Golgin_A | 3.91e-08 | 18 | 37 | 4 | IPR024858 | |
| Domain | Spectrin | 9.41e-04 | 23 | 37 | 2 | PF00435 | |
| Domain | Spectrin_repeat | 1.50e-03 | 29 | 37 | 2 | IPR002017 | |
| Domain | Spectrin/alpha-actinin | 1.82e-03 | 32 | 37 | 2 | IPR018159 | |
| Domain | SPEC | 1.82e-03 | 32 | 37 | 2 | SM00150 | |
| Domain | - | 9.19e-03 | 73 | 37 | 2 | 2.60.120.260 | |
| Domain | PH_dom-like | 9.73e-03 | 426 | 37 | 4 | IPR011993 | |
| Pathway | WP_15Q133_COPY_NUMBER_VARIATION_SYNDROME | 1.50e-05 | 23 | 30 | 3 | M39883 | |
| Pathway | REACTOME_GOLGI_CISTERNAE_PERICENTRIOLAR_STACK_REORGANIZATION | 1.50e-05 | 23 | 30 | 3 | MM14620 | |
| Pathway | REACTOME_COPI_MEDIATED_ANTEROGRADE_TRANSPORT | 8.23e-05 | 110 | 30 | 4 | MM15350 | |
| Pathway | WP_15Q11Q13_COPY_NUMBER_VARIATION | 2.61e-04 | 59 | 30 | 3 | M48104 | |
| Pathway | REACTOME_RHOD_GTPASE_CYCLE | 3.32e-04 | 64 | 30 | 3 | MM15601 | |
| Pathway | REACTOME_ER_TO_GOLGI_ANTEROGRADE_TRANSPORT | 4.19e-04 | 168 | 30 | 4 | MM14785 | |
| Pathway | WP_PATHOPHYSIOLOGICAL_ROLES_OF_DUX4_IN_FSHD1 | 6.56e-04 | 18 | 30 | 2 | M48069 | |
| Pathway | REACTOME_COPII_MEDIATED_VESICLE_TRANSPORT | 7.12e-04 | 83 | 30 | 3 | MM14819 | |
| Pubmed | Stage-dependent function of Wnt5a during male external genitalia development. | 5.74e-09 | 19 | 40 | 4 | 34255394 | |
| Pubmed | Ror2 enhances polarity and directional migration of primordial germ cells. | 8.85e-09 | 21 | 40 | 4 | 22216013 | |
| Pubmed | 1.57e-08 | 24 | 40 | 4 | 38814743 | ||
| Pubmed | 1.57e-08 | 24 | 40 | 4 | 24161848 | ||
| Pubmed | CFP1 Regulates Histone H3K4 Trimethylation and Developmental Potential in Mouse Oocytes. | 1.86e-08 | 25 | 40 | 4 | 28768200 | |
| Pubmed | 8.60e-08 | 36 | 40 | 4 | 30026494 | ||
| Pubmed | 1.47e-07 | 41 | 40 | 4 | 26685160 | ||
| Pubmed | 1.47e-07 | 41 | 40 | 4 | 30022023 | ||
| Pubmed | Globozoospermia and lack of acrosome formation in GM130-deficient mice. | 4.00e-07 | 13 | 40 | 3 | 28055014 | |
| Pubmed | GM130 regulates pulmonary surfactant protein secretion in alveolar type II cells. | 4.00e-07 | 13 | 40 | 3 | 33740186 | |
| Pubmed | Loss of GM130 does not impair oocyte meiosis and embryo development in mice. | 4.00e-07 | 13 | 40 | 3 | 32873390 | |
| Pubmed | 4.00e-07 | 13 | 40 | 3 | 21552007 | ||
| Pubmed | GOLGA2 loss causes fibrosis with autophagy in the mouse lung and liver. | 4.00e-07 | 13 | 40 | 3 | 29128360 | |
| Pubmed | Loss of the golgin GM130 causes Golgi disruption, Purkinje neuron loss, and ataxia in mice. | 4.00e-07 | 13 | 40 | 3 | 28028212 | |
| Pubmed | 5.08e-07 | 14 | 40 | 3 | 30630895 | ||
| Pubmed | 5.08e-07 | 14 | 40 | 3 | 37831422 | ||
| Pubmed | Golgb1 regulates protein glycosylation and is crucial for mammalian palate development. | 5.08e-07 | 14 | 40 | 3 | 27226319 | |
| Pubmed | Oligoasthenoteratospermia and sperm tail bending in PPP4C-deficient mice. | 5.08e-07 | 14 | 40 | 3 | 33543287 | |
| Pubmed | GM130 Regulates Golgi-Derived Spindle Assembly by Activating TPX2 and Capturing Microtubules. | 6.35e-07 | 15 | 40 | 3 | 26165940 | |
| Pubmed | Calumin, a novel Ca2+-binding transmembrane protein on the endoplasmic reticulum. | 6.35e-07 | 15 | 40 | 3 | 17204322 | |
| Pubmed | 6.35e-07 | 15 | 40 | 3 | 16413118 | ||
| Pubmed | Golgi disruption and early embryonic lethality in mice lacking USO1. | 6.35e-07 | 15 | 40 | 3 | 23185636 | |
| Pubmed | The a3 isoform of V-ATPase regulates insulin secretion from pancreatic beta-cells. | 6.35e-07 | 15 | 40 | 3 | 17046993 | |
| Pubmed | Mouse oocytes within germ cell cysts and primordial follicles contain a Balbiani body. | 6.35e-07 | 15 | 40 | 3 | 17189423 | |
| Pubmed | 6.35e-07 | 15 | 40 | 3 | 26083584 | ||
| Pubmed | 6.35e-07 | 15 | 40 | 3 | 37635409 | ||
| Pubmed | Golga5 is dispensable for mouse embryonic development and postnatal survival. | 6.35e-07 | 15 | 40 | 3 | 28509431 | |
| Pubmed | 7.81e-07 | 16 | 40 | 3 | 16399995 | ||
| Pubmed | 7.81e-07 | 16 | 40 | 3 | 11784862 | ||
| Pubmed | p125/Sec23-interacting protein (Sec23ip) is required for spermiogenesis. | 7.81e-07 | 16 | 40 | 3 | 21640725 | |
| Pubmed | 7.81e-07 | 16 | 40 | 3 | 16336229 | ||
| Pubmed | 7.81e-07 | 16 | 40 | 3 | 18166528 | ||
| Pubmed | Phospholipase D2 localizes to the plasma membrane and regulates angiotensin II receptor endocytosis. | 9.48e-07 | 17 | 40 | 3 | 14718562 | |
| Pubmed | 9.48e-07 | 17 | 40 | 3 | 28717168 | ||
| Pubmed | 9.48e-07 | 17 | 40 | 3 | 27655914 | ||
| Pubmed | 9.48e-07 | 17 | 40 | 3 | 14728599 | ||
| Pubmed | 9.48e-07 | 17 | 40 | 3 | 20004763 | ||
| Pubmed | 1.14e-06 | 18 | 40 | 3 | 21147753 | ||
| Pubmed | 1.14e-06 | 18 | 40 | 3 | 24227724 | ||
| Pubmed | 1.14e-06 | 18 | 40 | 3 | 22718342 | ||
| Pubmed | 1.14e-06 | 18 | 40 | 3 | 20943658 | ||
| Pubmed | 1.14e-06 | 18 | 40 | 3 | 15800058 | ||
| Pubmed | Altered GLUT4 trafficking in adipocytes in the absence of the GTPase Arfrp1. | 1.14e-06 | 18 | 40 | 3 | 20230794 | |
| Pubmed | Protein kinase LKB1 regulates polarized dendrite formation of adult hippocampal newborn neurons. | 1.14e-06 | 18 | 40 | 3 | 24367100 | |
| Pubmed | 1.14e-06 | 18 | 40 | 3 | 25208654 | ||
| Pubmed | Wnt5a is necessary for normal kidney development in zebrafish and mice. | 1.29e-06 | 2 | 40 | 2 | 25412793 | |
| Pubmed | 1.35e-06 | 19 | 40 | 3 | 23444373 | ||
| Pubmed | 1.35e-06 | 19 | 40 | 3 | 12646573 | ||
| Pubmed | CLASP2 safeguards hematopoietic stem cell properties during mouse and fish development. | 1.35e-06 | 19 | 40 | 3 | 35705037 | |
| Pubmed | Divergent functions and distinct localization of the Notch ligands DLL1 and DLL3 in vivo. | 1.35e-06 | 19 | 40 | 3 | 17664336 | |
| Pubmed | 1.35e-06 | 19 | 40 | 3 | 17724343 | ||
| Pubmed | Cell influx and contractile actomyosin force drive mammary bud growth and invagination. | 1.35e-06 | 19 | 40 | 3 | 34042944 | |
| Pubmed | 1.35e-06 | 19 | 40 | 3 | 15452145 | ||
| Pubmed | Scrg1, a novel protein of the CNS is targeted to the large dense-core vesicles in neuronal cells. | 1.35e-06 | 19 | 40 | 3 | 14622145 | |
| Pubmed | Deletion of IFT20 exclusively in the RPE ablates primary cilia and leads to retinal degeneration. | 1.35e-06 | 19 | 40 | 3 | 38048369 | |
| Pubmed | 1.35e-06 | 19 | 40 | 3 | 22841714 | ||
| Pubmed | Regulation of amino acid transporter ATA2 by ubiquitin ligase Nedd4-2. | 1.35e-06 | 19 | 40 | 3 | 17003038 | |
| Pubmed | 1.58e-06 | 20 | 40 | 3 | 23918928 | ||
| Pubmed | The COPI vesicle complex binds and moves with survival motor neuron within axons. | 1.58e-06 | 20 | 40 | 3 | 21300694 | |
| Pubmed | Intraflagellar transport molecules in ciliary and nonciliary cells of the retina. | 1.58e-06 | 20 | 40 | 3 | 20368623 | |
| Pubmed | Maximizing the ovarian reserve in mice by evading LINE-1 genotoxicity. | 1.58e-06 | 20 | 40 | 3 | 31949138 | |
| Pubmed | Development of the post-natal growth plate requires intraflagellar transport proteins. | 1.58e-06 | 20 | 40 | 3 | 17359961 | |
| Pubmed | The molecular complex of ciliary and golgin protein is crucial for skull development. | 1.58e-06 | 20 | 40 | 3 | 34128978 | |
| Pubmed | 1.58e-06 | 20 | 40 | 3 | 30236446 | ||
| Pubmed | Overlapping Role of SCYL1 and SCYL3 in Maintaining Motor Neuron Viability. | 1.58e-06 | 20 | 40 | 3 | 29437892 | |
| Pubmed | Canonical and noncanonical intraflagellar transport regulates craniofacial skeletal development. | 1.85e-06 | 21 | 40 | 3 | 27118846 | |
| Pubmed | 1.85e-06 | 21 | 40 | 3 | 21645620 | ||
| Pubmed | 1.85e-06 | 21 | 40 | 3 | 36292593 | ||
| Pubmed | Rap2 function requires palmitoylation and recycling endosome localization. | 1.85e-06 | 21 | 40 | 3 | 19061864 | |
| Pubmed | 1.85e-06 | 21 | 40 | 3 | 15229288 | ||
| Pubmed | Mechanism of primitive duct formation in the pancreas and submandibular glands: a role for SDF-1. | 1.85e-06 | 21 | 40 | 3 | 20003423 | |
| Pubmed | 1.85e-06 | 21 | 40 | 3 | 23386608 | ||
| Pubmed | Control of craniofacial development by the collagen receptor, discoidin domain receptor 2. | 2.14e-06 | 22 | 40 | 3 | 36656123 | |
| Pubmed | 2.14e-06 | 22 | 40 | 3 | 34897463 | ||
| Pubmed | 2.46e-06 | 23 | 40 | 3 | 25636444 | ||
| Pubmed | 2.46e-06 | 23 | 40 | 3 | 37848288 | ||
| Pubmed | 2.46e-06 | 23 | 40 | 3 | 18662990 | ||
| Pubmed | Reelin and stk25 have opposing roles in neuronal polarization and dendritic Golgi deployment. | 2.46e-06 | 23 | 40 | 3 | 21111240 | |
| Pubmed | 2.46e-06 | 23 | 40 | 3 | 18001291 | ||
| Pubmed | Pofut1 is required for the proper localization of the Notch receptor during mouse development. | 2.46e-06 | 23 | 40 | 3 | 18547789 | |
| Pubmed | 2.80e-06 | 24 | 40 | 3 | 26060116 | ||
| Pubmed | Essential role of cyclin-G-associated kinase (Auxilin-2) in developing and mature mice. | 2.80e-06 | 24 | 40 | 3 | 18434600 | |
| Pubmed | 2.80e-06 | 24 | 40 | 3 | 21187406 | ||
| Pubmed | The PCP genes Celsr1 and Vangl2 are required for normal lung branching morphogenesis. | 2.80e-06 | 24 | 40 | 3 | 20223754 | |
| Pubmed | Dual role for CXCL12 signaling in semilunar valve development. | 2.80e-06 | 24 | 40 | 3 | 34433040 | |
| Pubmed | Stalk cell phenotype depends on integration of Notch and Smad1/5 signaling cascades. | 2.80e-06 | 24 | 40 | 3 | 22364862 | |
| Pubmed | 3.18e-06 | 25 | 40 | 3 | 26582200 | ||
| Pubmed | Nubp1 is required for lung branching morphogenesis and distal progenitor cell survival in mice. | 3.18e-06 | 25 | 40 | 3 | 23028652 | |
| Pubmed | Cargo-selective endosomal sorting for retrieval to the Golgi requires retromer. | 3.18e-06 | 25 | 40 | 3 | 15078902 | |
| Pubmed | 3.18e-06 | 25 | 40 | 3 | 26143639 | ||
| Pubmed | Gestational stress induces the unfolded protein response, resulting in heart defects. | 3.18e-06 | 25 | 40 | 3 | 27436040 | |
| Pubmed | 3.18e-06 | 25 | 40 | 3 | 29587143 | ||
| Pubmed | 3.18e-06 | 25 | 40 | 3 | 27471260 | ||
| Pubmed | 3.18e-06 | 25 | 40 | 3 | 24161523 | ||
| Pubmed | 3.60e-06 | 26 | 40 | 3 | 22806269 | ||
| Pubmed | Dual function of Yap in the regulation of lens progenitor cells and cellular polarity. | 3.60e-06 | 26 | 40 | 3 | 24384391 | |
| Pubmed | 3.60e-06 | 26 | 40 | 3 | 19474315 | ||
| Pubmed | Mouse oocytes develop in cysts with the help of nurse cells. | 3.60e-06 | 26 | 40 | 3 | 35623357 | |
| Pubmed | Dynein activating adaptor BICD2 controls radial migration of upper-layer cortical neurons in vivo. | 3.60e-06 | 26 | 40 | 3 | 31655624 | |
| Pubmed | Endophilin-A2 dependent VEGFR2 endocytosis promotes sprouting angiogenesis. | 3.60e-06 | 26 | 40 | 3 | 31138815 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr15q13 | 2.74e-08 | 100 | 40 | 5 | chr15q13 | |
| Cytoband | 15q13.2 | 1.54e-04 | 21 | 40 | 2 | 15q13.2 | |
| Cytoband | 17q25.3 | 3.54e-03 | 101 | 40 | 2 | 17q25.3 | |
| GeneFamily | Dyneins, axonemal | 2.27e-04 | 17 | 24 | 2 | 536 | |
| ToppCell | COVID_non-vent-Lymphocytic-ILC|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 4.91e-10 | 199 | 40 | 7 | df4f7d5be099e3e6054f3b812ccf70251664e4c0 | |
| ToppCell | COVID_vent-Lymphocytic-ILC|COVID_vent / Disease condition, Lineage, Cell class and subclass | 4.91e-10 | 199 | 40 | 7 | e3ff7fa1b1de1aaf6b46cdf49afa95bad457728a | |
| ToppCell | COVID_vent-Lymphocytic-ILC-NK_cell|COVID_vent / Disease condition, Lineage, Cell class and subclass | 4.91e-10 | 199 | 40 | 7 | 5f914962e2572b0c6372465b81b7496fa663d93c | |
| ToppCell | COVID_non-vent-Lymphocytic-ILC-NK_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 4.91e-10 | 199 | 40 | 7 | ed35d747f11f6ea6a5cb7061057f0a98d9e0db99 | |
| ToppCell | COVID-19_Severe-gd_T|COVID-19_Severe / Disease condition and Cell class | 6.35e-07 | 184 | 40 | 5 | 791f1bcb954aadc63d4117c400537d036f68734d | |
| ToppCell | COVID-19_Severe-Lymphoid_T/NK-gd_T|COVID-19_Severe / Disease group, lineage and cell class | 8.45e-07 | 195 | 40 | 5 | 9990440bda7fac5d00ef80444fab07459be625e1 | |
| ToppCell | URO-Lymphocyte-T_NK-NK|URO / Disease, Lineage and Cell Type | 9.11e-07 | 198 | 40 | 5 | 2ccff882aafabf041df15b31d9abc50dcbc2696e | |
| ToppCell | healthy_donor-Lymphocytic-ILC-NK_cell|healthy_donor / Disease condition, Lineage, Cell class and subclass | 9.11e-07 | 198 | 40 | 5 | d7053a898e04478c577381085f615edaad3cdc5b | |
| ToppCell | healthy_donor-Lymphocytic-ILC|healthy_donor / Disease condition, Lineage, Cell class and subclass | 9.11e-07 | 198 | 40 | 5 | aa33be29e26f1b8facfc894413099083ae3bbb1b | |
| ToppCell | Sepsis-URO-Lymphocyte-T/NK-NK|URO / Disease, condition lineage and cell class | 9.57e-07 | 200 | 40 | 5 | 741c7bad606c7e4d7db57d89aaf4dcf4232fa82a | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK-NK_activated|COVID-19_Mild / Disease, condition lineage and cell class | 9.57e-07 | 200 | 40 | 5 | 2281debd86e5d92e8fe0397aec9ef670800f7471 | |
| ToppCell | COVID-19-COVID-19_Severe-Lymphocyte-T/NK-gd_T|COVID-19_Severe / Disease, condition lineage and cell class | 9.57e-07 | 200 | 40 | 5 | f72bc3f6606ae77fe1b0a972e35b3ce0727804d9 | |
| ToppCell | 368C-Lymphocytic-NK_cells-NK_cell_A|368C / Donor, Lineage, Cell class and subclass (all cells) | 8.88e-06 | 146 | 40 | 4 | 0e38e1fa40b1fcd1bb61f7af7cc2206846c192ae | |
| ToppCell | 367C-Lymphocytic-NK_cells-NK_cell_B2|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.34e-05 | 162 | 40 | 4 | 59c0dcb5b51c1803660aeec51b60deceeeaeea66 | |
| ToppCell | normal-na-Lymphocytic_NK-NK_bright-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 1.40e-05 | 164 | 40 | 4 | b5a91f2cbfad9a2bc38aea576085a37865df955d | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.58e-05 | 169 | 40 | 4 | fba841664939c771881ba97f14ef1df6635c04ff | |
| ToppCell | NS-critical-LOC-Lymphoid-NK|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.65e-05 | 171 | 40 | 4 | adda76991d9b150bb8ccf3989b7cbbf41843cf0b | |
| ToppCell | 5'-Adult-Appendix-Hematopoietic-T_cells-NK_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.69e-05 | 172 | 40 | 4 | f3c16a62eba1ed190318beee131c71c5150b266a | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c05-ZNF683|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.85e-05 | 176 | 40 | 4 | 5914e7635474e7cf24d446bdb1423bc0807ee9c6 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.89e-05 | 177 | 40 | 4 | d3e6c768b88b7906f3c7fdd00ba20842212c14b1 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.89e-05 | 177 | 40 | 4 | f8f101c772c043636bedd6b2ec81409b1d2599bf | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.89e-05 | 177 | 40 | 4 | 936ab2b180a052387124f68d0c7f41c0b164e748 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.89e-05 | 177 | 40 | 4 | d5aeda113afaa2425874394610344570c9078478 | |
| ToppCell | COVID-19_Mild-Lymphoid_T/NK-NK_activated|COVID-19_Mild / Disease group, lineage and cell class | 1.89e-05 | 177 | 40 | 4 | 6978a22fef40c8b455342373abe7593f5ede0fa4 | |
| ToppCell | cellseq2-Immune-Lymphocytic_T/NK-Lymphocytic_T/NK-NK|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.11e-05 | 182 | 40 | 4 | 8ccffcbae28c374fd4161fb0d4cf2c49fae557f6 | |
| ToppCell | COVID-19_Mild-NK_activated|COVID-19_Mild / Disease condition and Cell class | 2.16e-05 | 183 | 40 | 4 | 22bd05135906d0ecc4ba8c2e0a666093d1bf3b8f | |
| ToppCell | normal-na-Lymphocytic_NK-NK_dim-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 2.25e-05 | 185 | 40 | 4 | b1a8a8c4d0fc7605eabc17dcb6bd9e8ab4fd578c | |
| ToppCell | IIH-NK|IIH / Condition, Cell_class and T cell subcluster | 2.30e-05 | 186 | 40 | 4 | cab1249b849013cf0334f25ee8d840f0521f4eb8 | |
| ToppCell | IIH-NK-|IIH / Condition, Cell_class and T cell subcluster | 2.30e-05 | 186 | 40 | 4 | 2c90b45c8ccfd86bbf6840dba7f0d7f08b5ea914 | |
| ToppCell | 10x5'v1-week_12-13-Lymphocytic_NK-T_NK-mature_NK|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.30e-05 | 186 | 40 | 4 | 165d02be3b3eaeb8784a2b0b2020928b21a19bc7 | |
| ToppCell | 10x_3'_v3-thymus_(10x_3'_v3)-lymphocytic-innate_lymphocytic-mature_NK_T_cell|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.30e-05 | 186 | 40 | 4 | c984e5729958237b101df96d1c89a236faacded6 | |
| ToppCell | 10x5'-Lung-Lymphocytic_Invariant-Inducer-like-ILC3|Lung / Manually curated celltypes from each tissue | 2.35e-05 | 187 | 40 | 4 | 0e7aa481effdd8c2fbdf8b65852821dec2d92cde | |
| ToppCell | COVID-NK-|COVID / Condition, Cell_class and T cell subcluster | 2.40e-05 | 188 | 40 | 4 | fabdd68a9734d35e75e1f4a4bfd5c531cfc099f1 | |
| ToppCell | COVID-NK|COVID / Condition, Cell_class and T cell subcluster | 2.40e-05 | 188 | 40 | 4 | 0beaa671611110a11e46156f54f5202cc24967a4 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-CD8-positive,_alpha-beta_T_cell-CD8_T_cells-CD8_T_cells_L.1.1.4.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.50e-05 | 190 | 40 | 4 | d153a0bdedcd6865e6ee19575234a78b5d859ff1 | |
| ToppCell | MS-NK|MS / Condition, Cell_class and T cell subcluster | 2.60e-05 | 192 | 40 | 4 | f44f5dd30db169fdd16c9d706d17ad44907a17af | |
| ToppCell | MS-NK-|MS / Condition, Cell_class and T cell subcluster | 2.60e-05 | 192 | 40 | 4 | f97f5f8226f5c65ca93072ef35d753231bee2490 | |
| ToppCell | 3'_v3-bone_marrow-Lymphocytic_NK|bone_marrow / Manually curated celltypes from each tissue | 2.66e-05 | 193 | 40 | 4 | e790ab76c12f74a13936c231076f1e397283efb3 | |
| ToppCell | CD8+_Memory_T_cell-CV-0|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 2.66e-05 | 193 | 40 | 4 | 995781d87a919c0380750878bafe584342bb83ad | |
| ToppCell | severe-low-quality_cells|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.66e-05 | 193 | 40 | 4 | 9337bc93e3904c7fc7c93c328518bcd6453b1e8c | |
| ToppCell | E15.5-Mesenchymal-myocytic_cell-aortic_smooth_muscle_cell|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.66e-05 | 193 | 40 | 4 | e787e618f6e8a1e22be366ce606bf78831b60a90 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Lymphoid-CD4/CD8-CD8_NK_sig-C|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.71e-05 | 194 | 40 | 4 | 6be74e4ba631b0c46cef2c580553f4c1ed29579e | |
| ToppCell | 3'_v3-bone_marrow-Lymphocytic_NK-NK_CD16|bone_marrow / Manually curated celltypes from each tissue | 2.71e-05 | 194 | 40 | 4 | 7773501e076d470158dbc1d7f10c67152b326eb7 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c07-TYROBP|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.71e-05 | 194 | 40 | 4 | 52e09b14159b609af00264a8f38accf37ba8f464 | |
| ToppCell | CV-Moderate-0|CV / Virus stimulation, Condition and Cluster | 2.71e-05 | 194 | 40 | 4 | 9ff69139dae007fcc349daefcb5021defb0e0d2a | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T-gd_T-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.82e-05 | 196 | 40 | 4 | 6beaf0c2799424c59819b286fbb5c1a83d85e4d1 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T-gd_T|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.82e-05 | 196 | 40 | 4 | c35f2349dfe35baa845f790b9f31673dceac54c0 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T-gd_T|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.82e-05 | 196 | 40 | 4 | 418e8e0a51c5cb60e3b903e7d2d800dc8b9f3d5c | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.82e-05 | 196 | 40 | 4 | a9157809122e6fc5783a291522f103bef30943e4 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T-gd_T-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.82e-05 | 196 | 40 | 4 | 581fc8c8d42005aacd7b401a2c9d1fc331fb4af7 | |
| ToppCell | VE-NK|VE / Condition, Cell_class and T cell subcluster | 2.88e-05 | 197 | 40 | 4 | cae6ff8763501e7a5897b50188ac2640d65a47c0 | |
| ToppCell | severe-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.88e-05 | 197 | 40 | 4 | 57ebd552f10d6278623b52a3d484d4b91ae1d028 | |
| ToppCell | normal-na-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-female|normal / PBMC cell types (v2) per disease, treatment status, and sex | 2.88e-05 | 197 | 40 | 4 | b5b333e98753946793ceb45e2d85c25ef53568b4 | |
| ToppCell | mild-low-quality_cells|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.88e-05 | 197 | 40 | 4 | e4331969bd911d1ebb5453f40a7057297b5389b4 | |
| ToppCell | Parenchymal-10x3prime_v2-Immune_Lymphocytic-NK-ILC-T_NK-NK_CD11d|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 2.88e-05 | 197 | 40 | 4 | 52246d1354c4e2b13d48c878643edf843d2b50d2 | |
| ToppCell | VE-NK-|VE / Condition, Cell_class and T cell subcluster | 2.88e-05 | 197 | 40 | 4 | ee89b8521fb4faaed9e4d39f7171e45eccf38b00 | |
| ToppCell | normal-na-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell|normal / PBMC cell types (v2) per disease, treatment status, and sex | 2.88e-05 | 197 | 40 | 4 | 4cec48e202f4583c9328d4b722c49ed3471ec173 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c08-IL2RB|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.88e-05 | 197 | 40 | 4 | b6689a3e01e4c285fc2cb33f8c437078722a3892 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-NK_cell-NK_activated-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.94e-05 | 198 | 40 | 4 | ce92d5fbc2eac27fb246b044fb1914ab92506275 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-NK_cell-NK_activated|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.94e-05 | 198 | 40 | 4 | fed823d6e684d113bcc9ff3cd1803bb001aa02fa | |
| ToppCell | mild_COVID-19_(asymptomatic)-NK|World / disease group, cell group and cell class (v2) | 2.94e-05 | 198 | 40 | 4 | 7a0aac52d785037455e068e1b25de4b2bf0fff79 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-NK_cell-NK_activated|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.94e-05 | 198 | 40 | 4 | 0e918e9db9b884f5328d438e90efe065e27266ee | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-NK_cell-NK_activated-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.94e-05 | 198 | 40 | 4 | 1ef3a6bd681c223eed58300348adfef89df5563c | |
| ToppCell | (0)_NK_cells|World / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 2.94e-05 | 198 | 40 | 4 | c91c3ccba118dffb12c0bf8036f51fc76f0e305d | |
| ToppCell | Sepsis-Leuk-UTI-Lymphocyte-T/NK-gd_T|Leuk-UTI / Disease, condition lineage and cell class | 3.00e-05 | 199 | 40 | 4 | b2c1b9ee764e1246bfa3ecf666ca76ae4ac6c362 | |
| ToppCell | Caecum-(0)_NK_cell|Caecum / shred on region, Cell_type, and subtype | 3.00e-05 | 199 | 40 | 4 | 9ffff5c4ca10572d3c57b2ff1ca5415224b67cbe | |
| ToppCell | PBMC-Convalescent-Lymphocyte-T/NK-NK_cell-NK|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.00e-05 | 199 | 40 | 4 | fd3706f256e33cf348774bea0ba0df6d41fd96e3 | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.00e-05 | 199 | 40 | 4 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | PBMC-Convalescent-Lymphocyte-T/NK-NK_cell-NK-|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.00e-05 | 199 | 40 | 4 | 252f0084fa17770f4c34e21066519d7f7cad75d9 | |
| ToppCell | PBMC-Convalescent-Lymphocyte-T/NK-NK_cell-NK|Convalescent / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.00e-05 | 199 | 40 | 4 | 899642ff6bb6c1612f14a9a049b4344ae694752a | |
| ToppCell | PBMC-Convalescent-Lymphocyte-T/NK-NK_cell-NK-|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.00e-05 | 199 | 40 | 4 | e981b159841222a6838effff1059c683c20ecf5b | |
| ToppCell | Control-NK|Control / Disease condition and Cell class | 3.00e-05 | 199 | 40 | 4 | f3316fb97c6065286ffd22a0ad9fe7aa5b3b5650 | |
| ToppCell | COVID-19_Severe-Lymphoid_T/NK-NK_activated|COVID-19_Severe / Disease group, lineage and cell class | 3.00e-05 | 199 | 40 | 4 | edf5f80b4c299e6bf462675f2cd3329d86c923d8 | |
| ToppCell | PBMC-Convalescent-Lymphocyte-T/NK-NK_cell|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.00e-05 | 199 | 40 | 4 | 8cdd5aa30a8112b77f5d02b40c45b63f541e1476 | |
| ToppCell | COVID-19_Convalescent-Lymphoid_T/NK-NK|COVID-19_Convalescent / Disease group, lineage and cell class | 3.00e-05 | 199 | 40 | 4 | 9809d996a2c3f5384707646a3929e1d6b85dcdc2 | |
| ToppCell | COVID-19_Moderate-NK|World / disease group, cell group and cell class | 3.00e-05 | 199 | 40 | 4 | c41b67b760831c7d5e19fabcc932a056dc560f93 | |
| ToppCell | PBMC-Convalescent-Lymphocyte-T/NK-NK_cell|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.00e-05 | 199 | 40 | 4 | a2ac6af5e8e13e7edd3302ebdb175a3902bfb2bc | |
| ToppCell | Caecum-NK_cell-NK|Caecum / Region, Cell class and subclass | 3.00e-05 | 199 | 40 | 4 | e980998aa401c092d7d52575c97b95f908ecfd7b | |
| ToppCell | Caecum-(0)_NK_cell-(00)_NK|Caecum / shred on region, Cell_type, and subtype | 3.00e-05 | 199 | 40 | 4 | f5a44272e8a3c1ffeae61b478c3983df13bc9d53 | |
| ToppCell | Caecum-NK_cell|Caecum / Region, Cell class and subclass | 3.00e-05 | 199 | 40 | 4 | 2dffadf1c24169a9cb7f2bc83176d1fec9c6f77f | |
| ToppCell | remission-NK|remission / disease stage, cell group and cell class | 3.00e-05 | 199 | 40 | 4 | 31ed2a314e8f70980ea0686242446d66929288e9 | |
| ToppCell | severe-gd_T|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.00e-05 | 199 | 40 | 4 | e5a17a9f8f3be05d6abe1116607d17633df3c7ef | |
| ToppCell | COVID-19-COVID-19_Convalescent-Lymphocyte-T/NK-NK|COVID-19_Convalescent / Disease, condition lineage and cell class | 3.05e-05 | 200 | 40 | 4 | 50d844683dcfe35e59fffa0c23f1532d692d0c17 | |
| ToppCell | COVID-19-COVID-19_Severe-Lymphocyte-T/NK-NK_activated|COVID-19_Severe / Disease, condition lineage and cell class | 3.05e-05 | 200 | 40 | 4 | 6a77f9643646bafc1157bf1fc1e4c614860ee642 | |
| ToppCell | Sepsis-ICU-SEP-Lymphocyte-T/NK-NK|ICU-SEP / Disease, condition lineage and cell class | 3.05e-05 | 200 | 40 | 4 | 6813fa6d24950fac22e2b5bb26b64f79214163b6 | |
| ToppCell | COVID-19_Convalescent-NK|COVID-19_Convalescent / Disease condition and Cell class | 3.05e-05 | 200 | 40 | 4 | dd62477b12c54065d4b70866c1523e9c217a48a9 | |
| ToppCell | severe-NK|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.05e-05 | 200 | 40 | 4 | 64e8a6c36e0c654b7b2416c9f19b9058215222b1 | |
| ToppCell | severe-NK|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.05e-05 | 200 | 40 | 4 | d6767f06fe13be8110a86c2a6029be2dd9ce666c | |
| ToppCell | 3'_v3-blood-Lymphocytic_T_CD4-T_CD4/CD8|blood / Manually curated celltypes from each tissue | 2.41e-04 | 135 | 40 | 3 | ae2d3a42e567b5bade304c0caa497eb725be3565 | |
| ToppCell | 3'_v3-blood-Lymphocytic_T_CD4/8-lo-Tgd_CRTAM|blood / Manually curated celltypes from each tissue | 2.57e-04 | 138 | 40 | 3 | 9f8389a34c400a6b2b9bf6cef3a71499cc945e35 | |
| ToppCell | 390C-Lymphocytic-NK_cells-NK_cell_D3|390C / Donor, Lineage, Cell class and subclass (all cells) | 2.85e-04 | 143 | 40 | 3 | 10473c0f030d5ff760263042dc4b584787cb4a7f | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Lymphocytic-Lymphocytic_T-CD8-positive,_mature_gamma-delta_T_cell-T_gdT_c14-TRDV2|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.09e-04 | 147 | 40 | 3 | 22c9605869dd2e789896cd2790ee8def2605de57 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Lymphocytic-Lymphocytic_T-CD8-positive,_mature_gamma-delta_T_cell|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.09e-04 | 147 | 40 | 3 | ac272595818d25c6b84b107555b3351e912a01a7 | |
| ToppCell | 356C-Lymphocytic-NK_cells-NK_cell_C|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 3.21e-04 | 149 | 40 | 3 | 95b21d67d6c335330a508f78d5cc074fdaf92275 | |
| ToppCell | 367C-Lymphocytic-NK_cells-NK_cell_B0|367C / Donor, Lineage, Cell class and subclass (all cells) | 3.21e-04 | 149 | 40 | 3 | 41f28138bde45d0b814e116837e5a32b5e80d54a | |
| ToppCell | 390C-Fibroblasts-Fibroblast-G-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 3.41e-04 | 152 | 40 | 3 | ebce79e106bf1d84241f8dd3496ff1771f9666be | |
| ToppCell | 390C-Fibroblasts-Fibroblast-G|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 3.41e-04 | 152 | 40 | 3 | 4a749d1b6d35fd55a8c42d7bd04b6ff5b11ce781 | |
| ToppCell | PBMC-Mild-Myeloid-cDC-cDC-cDC_4|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.47e-04 | 153 | 40 | 3 | 91e9d70a5d3f6fd68c284ed0cc113f03d7d1e10b | |
| ToppCell | PBMC-Mild-Myeloid-cDC-cDC-cDC_4|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.47e-04 | 153 | 40 | 3 | f17f62646633cf95c810dcd5328978058741b276 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell_prolif|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.61e-04 | 155 | 40 | 3 | 5d157478669b609e1f0f0a75afd0112571fc2c46 | |
| Drug | diethyl acetylenedicarboxylate | 2.57e-06 | 2 | 37 | 2 | CID000069803 | |
| Disease | blood pressure | 2.76e-04 | 22 | 33 | 2 | EFO_0004325 | |
| Disease | endometrial carcinoma (is_marker_for) | 6.65e-04 | 34 | 33 | 2 | DOID:2871 (is_marker_for) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| WHRDYFLQELQRCLK | 216 | Q86VW2 | |
| QHKIETWREIYLQGC | 266 | Q9UGI9 | |
| KCLFVRPRHQNQEFW | 151 | Q6MZZ7 | |
| EAVLNNRFIKVYWHR | 591 | Q5T8P6 | |
| LRFIQYWQERCHQKI | 471 | H3BPF8 | |
| LRLWKRNHCNHRDYQ | 321 | P28039 | |
| RRNHARKQWEQKFCQ | 286 | Q9Y618 | |
| QELRFIQYWQERCHQ | 476 | H3BV12 | |
| CLQLQKDVVRVWFYN | 246 | Q8N7G0 | |
| HIYNRWKNSELRCYV | 306 | P50851 | |
| RDPQFQKLQQWYREH | 6 | P06744 | |
| LYWKNRTQEQCVHNE | 776 | O60313 | |
| HVCYEQAQRLVKDWD | 471 | Q8IYK2 | |
| QVQLLRLWYHENCRV | 2461 | Q9P2D7 | |
| QCNRHYCWEKLRRAE | 586 | Q9P0U4 | |
| VSECNYERWHKQRRV | 126 | Q9Y6A2 | |
| ELLRCHREKIYQQWV | 631 | Q9UFH2 | |
| YNRKQVLRHCFTEWQ | 396 | Q8NCU4 | |
| IWKDVRIEAYNICHL | 201 | O00462 | |
| LQCQWARREDYQKLE | 376 | Q8IX15 | |
| ELRFIQYWQERCHQK | 476 | I6L899 | |
| QELRFIQYWQERCHQ | 476 | A6NCC3 | |
| WKKLCQYHFSERQIR | 266 | Q969P5 | |
| DNQWHYVRAERNLKE | 871 | Q8WYK1 | |
| LQRCTAQWHDYQKAR | 5096 | Q8NF91 | |
| CRKIQEVWRQRYQSH | 536 | O15530 | |
| QELRFIQYWQERCHQ | 476 | H3BSY2 | |
| MNRQRLHCEYWNIAL | 826 | Q6Q759 | |
| CQVIHYRTDEYQKWL | 151 | P53675 | |
| FCIRVENDWHRVYLV | 4266 | Q63HN8 | |
| SDVKCVHIYENQRWN | 816 | Q7Z6L1 | |
| QNLAQKKCWENIRYR | 56 | O95183 | |
| IKECQYQFRHRRWNC | 101 | P41221 | |
| LLELWDERHRQYEQC | 461 | P02549 | |
| YRTRLHENNWICIQE | 76 | P07949 | |
| EQRIHQEEKAYWCNQ | 366 | Q96JF6 | |
| EQRTHQEKKVYWCNQ | 751 | Q96JF6 | |
| DYVLTCRWRNQALHF | 251 | Q8N5H7 | |
| RTLQEALKCNYEHWQ | 616 | Q6P3X3 | |
| REWQCLTYAQRHLYK | 76 | Q5JNZ3 | |
| QELRFIQYWQERCHQ | 476 | F8WBI6 | |
| IYWQQLREKCLLFSH | 96 | Q12918 |